Chinese Journal of Tissue Engineering Research ›› 2016, Vol. 20 ›› Issue (50): 7594-7600.doi: 10.3969/j.issn.2095-4344.2016.50.021

Previous Articles    

Icariin promotes the osteogenic differentiation of mesenchymal stem cells: a good candidate for bone defect repair

Chen Zhen-dong1, Gao Hui2, Xu Fang-tian2   

  1. 1Gannan Medical University, Ganzhou 341000, Jiangxi Province, China
    2First Clinical College of Gannan Medical University, Ganzhou 341000, Jiangxi Province, China
  • Revised:2016-09-07 Online:2016-12-02 Published:2016-12-02
  • Contact: Xu Fang-tian, M.D., Associate chief physician, Associate professor, First Clinical College of Gannan Medical University, Ganzhou 341000, Jiangxi Province, China
  • About author:Chen Zhen-dong, Studying for master’s degree, Physician, Gannan Medical University, Ganzhou 341000, Jiangxi Province, China
  • Supported by:

    the National Natural Science Foundation of China, No. 8156090191

Abstract:

BACKGROUND: Recent studies have shown that icariin is a good bone-inducing factor that can promote the osteogenic differentiation of mesenchymal stem cells, providing a new hope for the treatment of bone defects.
OBJECTIVE: To review research achievements in pharmacological effects of icariin effects on bone tissue metabolism as well as its effect to promote osteogenic differentiation of mesenchymal stem cells.
METHODS: The first author retrieved CNKI and PubMed databases for relevant Chinese and English literatures using keywords of “icariin, stem cell, osteogenesis”, respectively. Articles regarding icariin, stem cells, osteogenesis were included, and repetitive studies were excluded. Totally 754 articles were retrieved initially. In accordance with inclusion and exclusion criteria, 41 articles were included in result analysis.
RESULTS AND CONCLUSION: As the main ingredient of Herba epimedii, icariin functions as a good osteogenetic growth factor to promote the osteogenic differentiation of bone marrow mesenchymal stem cells. In recent years, icariin has been shown to promote adipose-, umbilical cord-, and periodontal ligament tissue-derived mesenchymal stem cells to differentiate into osteoblasts. But such studies are less reported. Until now, mesenchymal stem cells still exhibit unsatisfactory osteogenic ability in in vivo experiments. Given this, osteogenetic growth factors contribute to the osteogenic differentiation of mesenchymal stem cells. Therefore, the use of icariin is expected to provide a good strategy for bone defect repair.

 

 

Key words: Stem Cells, Tissue Engineering, Bone Marrow

CLC Number: